HIGHLIGHTS
- who: Daniel S. Thomas and colleagues from the Arizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA have published the research: In Silico Investigations of Multi-Drug Adaptive Therapy Protocols, in the Journal: Cancers 2022, x of /2022/
- what: 25 of 29 the work has some limitations.
- how: In contrast to previous single drug the authors explored the determinants of success of two-drug using an agent-based model. The authors described the details of the agent -based model using the standard overview design details (ODD) format from Grimm et_al . The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.